2012-02-11 04:02:18 - Fast Market Research recommends "Respiratory Distress Syndrome - Pipeline Review, H1 2012" from Global Markets Direct, now available

Respiratory Distress Syndrome - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Respiratory Distress Syndrome - Pipeline Review, H1 2012', provides an overview of the Respiratory Distress Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Respiratory Distress Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Respiratory Distress Syndrome. 'Respiratory Distress Syndrome - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections

in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Full Report Details at
- www.fastmr.com/prod/330165_respiratory_distress_syndrome_pipelin ..


Scope

* A snapshot of the global therapeutic scenario for Respiratory Distress Syndrome.
* A review of the Respiratory Distress Syndrome products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Respiratory Distress Syndrome pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Respiratory Distress Syndrome.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Respiratory Distress Syndrome pipeline depth and focus of Respiratory Distress Syndrome therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Respiratory Distress Syndrome Overview
Therapeutics Development
An Overview of Pipeline Products for Respiratory Distress Syndrome
Respiratory Distress Syndrome Therapeutics under Development by Companies
Respiratory Distress Syndrome Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Respiratory Distress Syndrome Therapeutics - Products under Development by Companies
Respiratory Distress Syndrome Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Respiratory Distress Syndrome Therapeutics Development
United Therapeutics Corporation
GlaxoSmithKline plc
Discovery Laboratories, Inc.
Pacgen Biopharmaceuticals Corporation
Advanced Life Sciences Holdings, Inc.
Altor BioScience Corporation
NovImmune SA
Ikaria Inc.
Kemin Industries, Inc.
Faron Pharmaceuticals, Ltd.
Respiratory Distress Syndrome - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Aviptadil - Drug Profile
ALS-886 - Drug Profile
NI-0101 - Drug Profile
SB681323 - Drug Profile
Aerosurf - Drug Profile
Surfaxin - Drug Profile
PAC-G31P - Drug Profile
ALT-836 - Drug Profile
APN01 - Drug Profile
KPE00001175 - Drug Profile
Celestone - Drug Profile
Calfactant - Drug Profile
IK-3001 - Drug Profile
Human albumin - Drug Profile
Hetastarch - Drug Profile
Poly-ICLC - Drug Profile
Dexamethasone - Drug Profile
FP-1201 - Drug Profile
GM-CSF - Drug Profile
Betamethasone - Drug Profile
5% Human Albumin - Drug Profile
Ibuprofen - Drug Profile
Insulin - Drug Profile
Surfaxin LS - Drug Profile
Betamethasone - Drug Profile
Betamethasone - Drug Profile
Interferon beta for neonatal respiratory distress syndrome - Drug Profile
Surfactant + Vitamin A - Drug Profile
Methylprednisolone - Drug Profile
Survanta - Drug Profile
Respiratory Distress Syndrome Therapeutics - Drug Profile Updates
Respiratory Distress Syndrome Therapeutics - Discontinued Products
Respiratory Distress Syndrome Therapeutics - Dormant Products
Respiratory Distress Syndrome - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Respiratory Distress Syndrome, H1 2012
Products under Development for Respiratory Distress Syndrome - Comparative Analysis, H1 2012
Number of Products under Development by Companies, H1 2012
Number of Products under Investigation by Universities/Institutes, H1 2012
Comparative Analysis by Late Stage Development, H1 2012
Comparative Analysis by Mid Clinical Stage Development, H1 2012
Comparative Analysis by Early Clinical Stage Development, H1 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=330165&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.